BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7792285)

  • 1. [Pulmonary manifestations of systemic scleroderma: pathophysiologic and clinical significance of the activation of lung fibroblasts].
    Behr J; Adelmann-Grill BC; Hein R; Schwaiblmair M; Degenkolb B; Krombach F; Fruhmann G
    Pneumologie; 1995 Apr; 49(4):266-72. PubMed ID: 7792285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Type III procollagen N-terminal peptide (P-III-P, prolyl hydroxylase (PH), and laminin P1 levels in serum and BALF of radiotherapy patients].
    Matsumoto S; Shindo J; Horiba M; Hara M; Inoue K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jan; 30(1):28-34. PubMed ID: 1320708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenetic and clinical significance of fibroblast activation in scleroderma lung disease.
    Behr J; Adelmann-Grill BC; Hein R; Beinert T; Schwaiblmair M; Krombach F; Fruhmann G
    Respiration; 1995; 62(4):209-16. PubMed ID: 8578017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast chemotactic response elicited by native bronchoalveolar lavage fluid from patients with fibrosing alveolitis.
    Behr J; Adelmann-Grill BC; Krombach F; Beinert T; Schwaiblmair M; Fruhmann G
    Thorax; 1993 Jul; 48(7):736-42. PubMed ID: 8153923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis.
    Atamas SP; Yurovsky VV; Wise R; Wigley FM; Goter Robinson CJ; Henry P; Alms WJ; White B
    Arthritis Rheum; 1999 Jun; 42(6):1168-78. PubMed ID: 10366109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of inflammation in the lung disease of systemic sclerosis: comparison with idiopathic pulmonary fibrosis.
    Owens GR; Paradis IL; Gryzan S; Medsger TA; Follansbee WP; Klein HA; Dauber JH
    J Lab Clin Med; 1986 Mar; 107(3):253-60. PubMed ID: 3950467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of abnormal bronchoalveolar lavage findings after cyclophosphamide treatment in scleroderma patients with interstitial lung disease.
    Mittoo S; Wigley FM; Wise R; Xiao H; Hummers L
    Arthritis Rheum; 2007 Dec; 56(12):4195-202. PubMed ID: 18050251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased procollagen III aminoterminal peptide-related antigens and fibroblast growth signals in the lungs of patients with idiopathic pulmonary fibrosis.
    Cantin AM; Boileau R; Bégin R
    Am Rev Respir Dis; 1988 Mar; 137(3):572-8. PubMed ID: 3345038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma.
    Ludwicka A; Ohba T; Trojanowska M; Yamakage A; Strange C; Smith EA; Leroy EC; Sutherland S; Silver RM
    J Rheumatol; 1995 Oct; 22(10):1876-83. PubMed ID: 8991985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type III and type I procollagen markers in fibrosing alveolitis.
    Lammi L; Ryhänen L; Lakari E; Risteli J; Pääkkö P; Kahlos K; Lähde S; Kinnula V
    Am J Respir Crit Care Med; 1999 Mar; 159(3):818-23. PubMed ID: 10051256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary involvement in diffuse cutaneous systemic sclerosis: broncheoalveolar fluid granulocytosis predicts progression of fibrosing alveolitis.
    Witt C; Borges AC; John M; Fietze I; Baumann G; Krause A
    Ann Rheum Dis; 1999 Oct; 58(10):635-40. PubMed ID: 10491363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different expression of endothelin in the bronchoalveolar lavage in patients with pulmonary diseases.
    Reichenberger F; Schauer J; Kellner K; Sack U; Stiehl P; Winkler J
    Lung; 2001; 179(3):163-74. PubMed ID: 11891606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Procollagen-III-peptide in bronchoalveolar lavage fluid as an index of fibrosis in sarcoidosis and idiopathic lung fibrosis?].
    Teschler H; Costabel U; Ziesche R; Freitag L; Matthys H; Konietzko N
    Pneumologie; 1990 Feb; 44 Suppl 1():217-8. PubMed ID: 2367369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BALF-derived fibroblasts differ from biopsy-derived fibroblasts in systemic sclerosis.
    Scheja A; Larsen K; Todorova L; Tufvesson E; Wildt M; Akesson A; Hansson L; Ellis S; Westergren Thorsson G
    Eur Respir J; 2007 Mar; 29(3):446-52. PubMed ID: 17107986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis.
    Prasse A; Pechkovsky DV; Toews GB; Schäfer M; Eggeling S; Ludwig C; Germann M; Kollert F; Zissel G; Müller-Quernheim J
    Arthritis Rheum; 2007 May; 56(5):1685-93. PubMed ID: 17469163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced sputum in systemic sclerosis interstitial lung disease: comparison to healthy controls and bronchoalveolar lavage.
    Damjanov N; Ostojic P; Kaloudi O; Alari S; Guiducci S; Stanflin N; Nestorovic B; Knezevic J; Camiciottoli G; Porta F; Pistolesi M; Ibba-Manneschi L; Conforti ML; Candelieri A; Matucci Cerinic M
    Respiration; 2009; 78(1):56-62. PubMed ID: 18931474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation between bronchoalveolar lavage and lung function in patients with systemic sclerosis and rheumatoid arthritis].
    Pejcić T; Stanković I; Rancić M; Djordjević I; Ristić L; Vojinović J
    Srp Arh Celok Lek; 2005 Dec; 133 Suppl 2():129-33. PubMed ID: 16535997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression.
    Goh NS; Veeraraghavan S; Desai SR; Cramer D; Hansell DM; Denton CP; Black CM; du Bois RM; Wells AU
    Arthritis Rheum; 2007 Jun; 56(6):2005-12. PubMed ID: 17530640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Markers of fibrogenesis in bronchoalveolar lavage and in serum of workers exposed to asbestos].
    Salberini I; Rivolta G; Todaro A; Forni A; Annoni G; Chiappino G
    Med Lav; 1991; 82(3):238-47. PubMed ID: 1795668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis.
    Andersson-Sjöland A; de Alba CG; Nihlberg K; Becerril C; Ramírez R; Pardo A; Westergren-Thorsson G; Selman M
    Int J Biochem Cell Biol; 2008; 40(10):2129-40. PubMed ID: 18374622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.